<?xml version="1.0" encoding="UTF-8"?>
<svg height="719.063" width="554.9114400030769" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 13 of 27</text>
  <text x="76.535,80.713,83.58,89.058,94.793,97.66,103.621,107.996,112.922,118.657,121.869,124.362,130.096,134.816,138.028,142.747,146.462,151.842,157.32,162.039,167.774,172.493,175.361,178.573,184.05100000000002,186.554,189.835" y="55.95799999999997" svg_rhmargin="193.155" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">signiﬁcant heterogeneity (I</text>
  <text svg_rhmargin="196.938" x="193.152,196.938" y="55.95799999999997" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.57px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text svg_rhmargin="228.989" x="199.933,205.904,208.397,213.323,218.25,226.526,228.989" y="55.95799999999997" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">= 78%, </text>
  <text svg_rhmargin="236.42" x="231.493,236.42" y="55.95799999999997" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">p </text>
  <text x="238.917,244.888,247.381,252.307,254.771,259.697,264.624,267.905,270.368,273.481,279.521,285.256,289.975,293.69,298.41,301.691,307.07,310.785,315.505,317.968,320.461,328.678,333.398,335.9,341.842,346.019,350.739,356.75899999999996,359.252,362.464,368.198,372.918,375.411,379.303,384.229,389.964,395.984,401.364,410.064,413.345,418.065,421.168,424.449,429.169,433.544,436.756,439.258,447.959,453.338,459.358,464.078,466.945,469.438,472.65,478.03,480.533,484.907,489.834,492.701,497.076,503.017,505.884,510.811,514.023" y="55.95799999999997" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">&lt; 0.01). Therefore, we used the random-effect model to calculate</text>
  <text x="76.535,79.718,85.4,90.077,98.698,101.139,104.224,110.209,115.891,120.56700000000001,123.048,128.378,133.895,138.571,142.428,147.31,150.151,152.99200000000002,155.462,161.33,166.66,171.991,174.832,179.509,185.474,187.954,194.877,201.398,207.92,210.4,215.731,218.982,221.452,228.375,235.97,242.492,244.972,250.95700000000002,253.437,256.62,262.302,266.979,270.835,275.717,281.585,287.013,289.483,292.735,298.065,301.921,304.402,310.27,315.151,318.334,321.175,325.852,331.534,334.717,338.85699999999997,341.337,349.479,352.32,355.503,361.185,363.656,367.795,373.126,375.967,378.808,384.77299999999997,387.254,392.135,397.818,403.78299999999996,406.263,411.945,416.622,425.243,430.124,433.307,438.638,441.479,446.81,452.238,455.08,459.41499999999996,461.885,470.506,475.387,478.228,481.07,486.498,492.18,497.062,502.744,507.079,509.92,514.597" y="69.46799999999996" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">them. The overall pooled CRR of CAR T therapy for patients with solid and hematologic malignancies</text>
  <text x="76.117,84.592,89.673,93.982,97.274,102.355,107.436,115.97200000000001,119.264,122.648,127.729,132.81,141.346,144.638,151.843,155.268,157.809,161.101,166.181,171.262,176.343,181.424,186.505,195.041,198.425,200.966,206.453,212.682,218.596,223.464,226.756,231.065,237.193,242.812,248.462,252.303,257.852,263.979,270.086,273.379,278.46,284.374,289.455,292.412,298.062,302.371,305.328,309.637,312.929,316.76,321.627,325.936,332.064,335.021,338.334,341.626,345.935,351.849,357.397,365.872,370.74,376.949,380.241,383.554,389.468,394.549,397.86199999999997,401.154,404.467,410.381,415.24899999999997,418.541,425.746,432.534,439.322,442.614,451.089,456.17,460.47900000000004,463.771,468.08,471.037,476.687,482.601,485.558,491.706,496.218,501.299,507.213,510.526,513.483" y="82.97699999999998" svg_rhmargin="519.133" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">was 42% (95% CI: 32–53%). The subgroup analysis result showed that the CRR was signiﬁcantly</text>
  <text x="76.535,82.339,85.241,90.786,96.59,101.367,105.30600000000001,107.799,111.12,116.565,120.50399999999999,122.997,128.991,133.977,137.228,140.13,144.907,150.711,153.962,158.191,160.674,168.991,171.893,175.144,180.948,183.441,189.245,194.022,202.828,207.814,211.065,216.51,219.412,224.857,230.402,233.304,237.732,240.225,249.03,254.017,256.919,259.821,265.365,271.169,276.156,281.96,286.388,289.29,294.066,298.29499999999996,300.788,304.109,309.095,314.081,322.458,324.951,327.435,332.421,337.407,345.784,348.277,355.348,358.709,361.202,363.695,368.681,373.667,378.654,383.64,388.626,397.003,400.324,402.817,407.245,412.69,421.496,427.489,432.475,436.235,441.012,447.106,449.598,452.849,458.294,460.778,466.771,471.757,475.008,477.91,482.687,488.491,491.742,495.971,498.464,506.781,509.683,512.934" y="96.48699999999997" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">higher for patients with hematologic malignancies (60%, 95% CI: 48–70%) compared to patients with</text>
  <text x="76.535,80.844,86.392,89.349,92.306,98.515,101.015,109.988,115.069,118.026,120.983,126.633,132.547,137.628,143.542,148.054,151.011,155.879,160.188,162.697,166.081,171.162,176.243,184.779,187.32,189.819,194.9,199.981,208.517,211.027,218.232,221.656,224.197,226.697,231.778,236.859,241.94,247.02,255.556,258.94,261.481,264.611,270.84,276.754,281.622,284.121,288.43,294.558,300.177,305.827,309.658,315.206,321.334,327.44100000000003,329.951,335.032,340.946,346.027,348.984,354.634,358.943,361.9,366.209,368.709,372.54,377.407,381.716,387.843,390.8,394.113,396.623,400.454,405.322,410.972,416.053,419.884,426.093,429.05,434.964,440.614,443.124,446.437,452.351,457.219,459.718,465.825,470.906,474.219,477.176,482.044,487.958,491.271,495.58000000000004,498.079,506.554,509.511,512.824" y="109.99599999999998" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">solid malignancies (11%, 95% CI: 7–19%). The subgroup analysis result regarding the patients with</text>
  <text x="76.535,82.744,85.701,88.902,92.286,97.153,100.984,105.852,111.766,115.07900000000001,117.711,123.92,127.304,131.815,136.683,139.64,142.59699999999998,145.219,154.192,159.273,162.23,165.187,170.837,176.751,181.832,187.746,192.258,195.215,200.083,204.392,207.023,210.407,216.057,219.014,224.664,230.792,234.623,239.49099999999999,242.112,247.193,252.813,256.197,258.828,263.137,269.051,274.6,283.075,287.942,294.151,296.773,300.086,306.0,311.081,314.394,317.025,320.338,326.252,331.12,333.742,340.946,347.734,354.522,357.155,362.703,366.087,368.709,374.816,379.897,383.21,386.167,391.034,396.948,400.261,404.57000000000005,407.192,415.667,418.624,421.936,427.84999999999997,430.482,438.388,444.597,450.806,453.347,455.968,464.423,470.632,473.173,475.804,484.249,492.703,498.912,501.534,506.615,512.529" y="123.505" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">different B-cell malignancies (Figure 3b) showed that the CRR of patients with ALL, HL, NHL and</text>
  <text x="76.535,83.74,89.949,96.158,99.47,107.945,112.813,116.654,121.52199999999999,124.834,129.915,134.996,143.532,146.855,150.239,155.32,160.401,168.937,172.249,179.454,182.879,185.42,188.742,193.823,198.904,203.985,209.066,214.147,222.683,226.067,228.608,232.123,237.204,242.285,250.821,254.144,257.528,262.609,267.69,276.226,279.538,286.743,290.168,292.709,296.031,301.112,306.193,311.274,316.355,324.891,328.275,330.816,334.341,339.422,344.503,353.039,356.352,359.736,364.817,369.898,378.434,381.746,388.951,392.376,394.917,398.239,403.32,408.401,413.482,418.563,423.644,432.18,435.564,438.876,443.957,449.871,456.08,459.403,464.484,469.565,478.101,481.414,484.798,489.879,494.96,503.496,506.819,514.023,517.448" y="137.015" svg_rhmargin="519.988" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">CLL were 76% (95% CI: 67–83%), 13% (95% CI: 1–72%), 35% (95% CI: 17–59%) and 48% (95% CI:</text>
  <text x="76.535,81.516,86.498,91.479,96.46,101.442,109.81,113.128,115.619,118.109,121.865,126.637,130.861,136.849,141.621,146.044,149.292,152.191,157.82,162.592,165.491,169.924" y="150.524" svg_rhmargin="172.415" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">22–76%), respectively.</text>
  <text x="64.099,69.857,73.693,78.494,82.011,85.373,88.735,92.098" y="154.562" svg_rhmargin="94.253" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:8.62px;font-style:ITALIC;font-weight:normal;">Cancers </text>
  <text x="94.231,98.573,102.914,107.256" y="154.562" svg_rhmargin="111.565" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:8.62px;font-style:NORMAL;font-weight:bold;">2018</text>
  <text x="111.597,113.735" y="154.562" svg_rhmargin="115.89" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:8.62px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="115.873,120.215" y="154.562" svg_rhmargin="124.524" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:8.62px;font-style:ITALIC;font-weight:normal;">10</text>
  <text x="124.556,126.714,128.852,133.303,135.458,516.791,521.131,523.269,528.006,530.857,532.995,537.335,541.675" y="154.562" svg_rhmargin="543.83" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:8.62px;font-style:NORMAL;font-weight:normal;">, x 4 of 29 </text>
  <text style="fill:#000000;font-family:IKMAII+TimesNewRoman;font-size:9.72px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="66.529" y="693.569" x=""/>
  <text y="693.569" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="482.496" x=""/>
  <rect style="stroke:blue;stroke-width:0.3;" x="125.983" y="170.115" height="523.519" width="353.873" title="13"/>
  <text x="125.983" y="170.115" class="image" id="image.13.1" width="353" height="523">image.13.1.126_480.170_694</text>
  <text svg_rhmargin="303.848" x="268.475,273.46,276.446,281.431,286.91,290.398,294.88100000000003,297.123,301.606,303.848" y="709.063" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Figure 3. </text>
  <text x="306.627,312.608,316.589,321.574" y="709.063" svg_rhmargin="324.56" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Cont</text>
  <text x="324.559" y="709.063" svg_rhmargin="326.801" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">.</text>
 </g>
</svg>
